See more : ZINEMA MEDIA AND ENTERTAINMENT (ZINEMA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of SciVision Biotech Inc. (1786.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SciVision Biotech Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- G.M. Breweries Limited (GMBREW.NS) Income Statement Analysis – Financial Results
- Pharma Mar, S.A. (0RC6.L) Income Statement Analysis – Financial Results
- Life Insurance Corporation of India (LICI.BO) Income Statement Analysis – Financial Results
- Formosa Laboratories, Inc. (4746.TW) Income Statement Analysis – Financial Results
- C-Link Squared Limited (1463.HK) Income Statement Analysis – Financial Results
SciVision Biotech Inc. (1786.TW)
About SciVision Biotech Inc.
SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. It offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. The company was founded in 2001 and is based in Kaohsiung, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 712.99M | 557.35M | 505.54M | 466.88M | 437.87M | 329.58M | 258.42M | 228.30M | 264.84M | 158.28M | 200.51M | 200.68M | 143.27M | 66.22M | 15.68M |
| Cost of Revenue | 200.49M | 185.48M | 163.70M | 123.60M | 132.42M | 112.66M | 105.59M | 101.15M | 109.27M | 78.80M | 84.81M | 77.50M | 52.37M | 43.12M | 28.10M |
| Gross Profit | 512.49M | 371.87M | 341.84M | 343.28M | 305.46M | 216.92M | 152.83M | 127.16M | 155.58M | 79.49M | 115.70M | 123.18M | 90.90M | 23.09M | -12.42M |
| Gross Profit Ratio | 71.88% | 66.72% | 67.62% | 73.53% | 69.76% | 65.82% | 59.14% | 55.70% | 58.74% | 50.22% | 57.70% | 61.38% | 63.45% | 34.87% | -79.20% |
| Research & Development | 53.42M | 52.46M | 65.94M | 59.78M | 43.25M | 47.98M | 39.25M | 30.50M | 24.86M | 37.24M | 26.41M | 26.94M | 17.73M | 20.03M | 21.13M |
| General & Administrative | 82.77M | 74.62M | 59.88M | 52.97M | 53.20M | 43.99M | 46.58M | 38.85M | 49.41M | 38.73M | 33.66M | 25.66M | 21.82M | 17.12M | 15.82M |
| Selling & Marketing | 176.67M | 110.18M | 94.07M | 83.89M | 74.82M | 44.30M | 35.85M | 30.00M | 41.16M | 38.86M | 25.82M | 19.57M | 15.43M | 13.63M | 11.29M |
| SG&A | 259.44M | 184.80M | 153.95M | 136.87M | 128.02M | 88.29M | 82.43M | 68.85M | 90.57M | 77.60M | 59.48M | 45.22M | 37.25M | 30.75M | 27.12M |
| Other Expenses | 0.00 | 36.73M | -324.00K | 13.34M | 6.49M | 15.12M | -4.29M | -53.81M | 6.86M | 13.23M | 1.59M | 95.00K | 7.47M | 12.36M | 8.60M |
| Operating Expenses | 312.86M | 237.26M | 219.89M | 196.64M | 171.27M | 136.26M | 121.68M | 99.34M | 115.43M | 114.84M | 85.89M | 72.16M | 54.98M | 50.78M | 48.25M |
| Cost & Expenses | 513.35M | 422.74M | 383.60M | 320.24M | 303.69M | 248.92M | 227.27M | 200.49M | 224.70M | 193.63M | 170.70M | 149.67M | 107.35M | 93.91M | 76.35M |
| Interest Income | 14.90M | 4.88M | 2.63M | 1.92M | 4.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 420.00K | 321.00K | 53.00K | 66.00K |
| Interest Expense | 8.22M | 6.46M | 8.07M | 7.47M | 6.40M | 2.68M | 4.19M | 5.14M | 233.00K | 17.00K | 31.00K | 3.00K | 266.00K | 1.55M | 1.65M |
| Depreciation & Amortization | 63.13M | 62.06M | 53.02M | 15.31M | 14.51M | 20.63M | 20.94M | 21.23M | 19.85M | 19.14M | 22.71M | 21.56M | 22.41M | 21.28M | 19.44M |
| EBITDA | 281.35M | 238.28M | 177.27M | 177.21M | 155.18M | 116.42M | 47.80M | -4.76M | 66.85M | -2.99M | 54.11M | 73.25M | 66.44M | 8.66M | -31.22M |
| EBITDA Ratio | 39.46% | 42.75% | 35.07% | 37.96% | 35.44% | 35.32% | 18.50% | -2.09% | 25.24% | -1.89% | 26.98% | 35.98% | 45.98% | 13.07% | -201.00% |
| Operating Income | 199.64M | 176.23M | 124.25M | 161.90M | 140.68M | 80.66M | 26.86M | -25.99M | 47.01M | -22.13M | 31.40M | 50.65M | 43.47M | -12.63M | -50.96M |
| Operating Income Ratio | 28.00% | 31.62% | 24.58% | 34.68% | 32.13% | 24.47% | 10.39% | -11.39% | 17.75% | -13.98% | 15.66% | 25.24% | 30.34% | -19.07% | -324.95% |
| Total Other Income/Expenses | 10.36M | 38.94M | -5.89M | 5.85M | 90.00K | 12.44M | -8.48M | -58.94M | 6.63M | 13.21M | 1.55M | 620.00K | 7.84M | 13.52M | 8.13M |
| Income Before Tax | 210.00M | 173.55M | 116.06M | 152.49M | 134.28M | 93.10M | 22.67M | -31.13M | 46.77M | -22.15M | 31.36M | 51.63M | 43.76M | -14.17M | -52.54M |
| Income Before Tax Ratio | 29.45% | 31.14% | 22.96% | 32.66% | 30.67% | 28.25% | 8.77% | -13.63% | 17.66% | -13.99% | 15.64% | 25.73% | 30.54% | -21.40% | -335.06% |
| Income Tax Expense | 32.10M | 31.83M | 14.34M | 24.48M | 13.57M | 6.23M | 5.53M | -4.87M | -8.07M | 0.00 | -8.99M | -10.80M | -7.40M | -7.31M | -9.00K |
| Net Income | 177.90M | 141.72M | 101.72M | 128.01M | 120.70M | 86.87M | 17.14M | -26.26M | 54.84M | -22.15M | 40.35M | 62.43M | 51.16M | -6.86M | -52.54M |
| Net Income Ratio | 24.95% | 25.43% | 20.12% | 27.42% | 27.57% | 26.36% | 6.63% | -11.50% | 20.71% | -13.99% | 20.12% | 31.11% | 35.71% | -10.37% | -335.00% |
| EPS | 2.66 | 2.14 | 1.54 | 1.93 | 1.84 | 1.46 | 0.28 | -0.44 | 0.90 | -0.36 | 0.75 | 1.18 | 1.00 | -0.16 | -1.26 |
| EPS Diluted | 2.33 | 1.92 | 1.51 | 1.88 | 1.78 | 1.46 | 0.28 | -0.44 | 0.89 | -0.36 | 0.75 | 1.18 | 1.00 | -0.16 | -1.26 |
| Weighted Avg Shares Out | 66.85M | 66.19M | 66.19M | 66.19M | 65.77M | 59.56M | 59.99M | 59.99M | 61.01M | 60.95M | 52.84M | 52.74M | 51.10M | 43.84M | 41.54M |
| Weighted Avg Shares Out (Dil) | 76.44M | 74.66M | 70.98M | 70.92M | 70.37M | 59.63M | 60.03M | 59.99M | 61.06M | 62.20M | 53.92M | 52.88M | 51.10M | 43.84M | 41.54M |
No news found for: 1786.TW
Source: https://incomestatements.info
Category: Stock Reports